CN117503617B - Superfine fiber mask cloth and preparation method and application thereof - Google Patents
Superfine fiber mask cloth and preparation method and application thereof Download PDFInfo
- Publication number
- CN117503617B CN117503617B CN202311762387.XA CN202311762387A CN117503617B CN 117503617 B CN117503617 B CN 117503617B CN 202311762387 A CN202311762387 A CN 202311762387A CN 117503617 B CN117503617 B CN 117503617B
- Authority
- CN
- China
- Prior art keywords
- mask
- cloth
- base cloth
- beta
- mask base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004744 fabric Substances 0.000 title claims abstract description 184
- 239000000835 fiber Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- AXFYFNCPONWUHW-UHFFFAOYSA-N 3-hydroxyisovaleric acid Chemical compound CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 claims abstract description 94
- 229920001410 Microfiber Polymers 0.000 claims abstract description 50
- 239000003658 microfiber Substances 0.000 claims abstract description 50
- 241000239290 Araneae Species 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 43
- 239000011550 stock solution Substances 0.000 claims abstract description 35
- 238000001035 drying Methods 0.000 claims abstract description 30
- 239000000243 solution Substances 0.000 claims abstract description 29
- YZYASTRURKBPPS-UHFFFAOYSA-N C(CCC(=O)OCCCCCC(C)C)(=O)OCCCCCC(C)C.[Na] Chemical compound C(CCC(=O)OCCCCCC(C)C)(=O)OCCCCCC(C)C.[Na] YZYASTRURKBPPS-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 229920001661 Chitosan Polymers 0.000 claims abstract description 16
- 238000010041 electrostatic spinning Methods 0.000 claims abstract description 14
- 238000012958 reprocessing Methods 0.000 claims abstract description 14
- 238000009987 spinning Methods 0.000 claims abstract description 14
- 239000003960 organic solvent Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 230000001815 facial effect Effects 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 238000010438 heat treatment Methods 0.000 claims description 23
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 8
- 239000004005 microsphere Substances 0.000 claims description 8
- 229920002635 polyurethane Polymers 0.000 claims description 8
- 239000004814 polyurethane Substances 0.000 claims description 8
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 7
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 7
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 229920002674 hyaluronan Polymers 0.000 claims description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 230000000052 comparative effect Effects 0.000 description 25
- 229920001872 Spider silk Polymers 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 8
- 239000004745 nonwoven fabric Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- MQKXWEJVDDRQKK-UHFFFAOYSA-N bis(6-methylheptyl) butanedioate Chemical compound CC(C)CCCCCOC(=O)CCC(=O)OCCCCCC(C)C MQKXWEJVDDRQKK-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 208000029549 Muscle injury Diseases 0.000 description 2
- 240000009002 Picea mariana Species 0.000 description 2
- 235000017997 Picea mariana var. mariana Nutrition 0.000 description 2
- 235000018000 Picea mariana var. semiprostrata Nutrition 0.000 description 2
- 108010020346 Polyglutamic Acid Proteins 0.000 description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 2
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- ZMZQVAUJTDKQGE-UHFFFAOYSA-N 2-ethylhydracrylic acid Chemical compound CCC(CO)C(O)=O ZMZQVAUJTDKQGE-UHFFFAOYSA-N 0.000 description 1
- QUKRTJQSGPLQKQ-UHFFFAOYSA-N 5-methylsulfonyl-3h-1,3-benzoxazol-2-one Chemical compound CS(=O)(=O)C1=CC=C2OC(=O)NC2=C1 QUKRTJQSGPLQKQ-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 230000037364 MAPK/ERK pathway Effects 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 102000038030 PI3Ks Human genes 0.000 description 1
- 108091007960 PI3Ks Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000026058 directional locomotion Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000025175 skeletal muscle hypertrophy Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/42—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
- D04H1/4382—Stretched reticular film fibres; Composite fibres; Mixed fibres; Ultrafine fibres; Fibres for artificial leather
- D04H1/43838—Ultrafine fibres, e.g. microfibres
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/10—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing oxygen
- D06M13/184—Carboxylic acids; Anhydrides, halides or salts thereof
- D06M13/207—Substituted carboxylic acids, e.g. by hydroxy or keto groups; Anhydrides, halides or salts thereof
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/244—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing sulfur or phosphorus
- D06M13/248—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing sulfur or phosphorus with compounds containing sulfur
- D06M13/256—Sulfonated compounds esters thereof, e.g. sultones
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/02—Natural fibres, other than mineral fibres
- D06M2101/10—Animal fibres
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/16—Synthetic fibres, other than mineral fibres
- D06M2101/30—Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M2101/38—Polyurethanes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Textile Engineering (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Respiratory Apparatuses And Protective Means (AREA)
Abstract
The invention discloses superfine fiber mask cloth and a preparation method and application thereof. The preparation of the mask cloth comprises the following steps of (1) preparing mask base cloth: uniformly mixing the fiber stock solution and chitosan according to the mass ratio of 2:5-3:2 to obtain spinning solution, and preparing the mask base cloth by using an electrostatic spinning method; the fiber stock solution comprises a spider silk-like microfiber stock solution; (2) pretreatment of mask base cloth: placing the mask base cloth into bath liquid for pretreatment for 40-50 min; the bath liquid is an organic solvent containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid; and (3) reprocessing the mask base cloth: and centrifugally dewatering the pretreated mask base cloth, and drying to obtain the mask cloth. The spider silk-like microfiber belongs to superfine fibers, and a proper amount of spider silk-like microfiber is added into the mask cloth, so that the spider silk-like microfiber has high load capacity for essence and high affinity for skin.
Description
Technical Field
The invention belongs to the technical field of mask cloth preparation, and particularly relates to superfine fiber mask cloth, and a preparation method and application thereof.
Background
In life, with the continuous growth of age, the human face also can slowly age, gradually lose activity and luster, in view of the situation, the rapid development of the beauty industry is promoted, and beauty products such as facial masks, eye cream, skin lotion and the like are also appeared on the market. In recent years, the mask market has rapidly developed, and mask products have become one of the most robustly-held products in the personal beauty care product market.
Most of the facial mask products take spunlaced non-woven fabrics as facial mask base fabrics, essence is loaded on the facial mask base fabrics, and then functional active substances with the effects of whitening, preventing aging, relieving skin, diminishing inflammation and the like are added into the essence to realize functionalization. Regarding the aspect of the material of the mask base cloth, the non-woven fabric mask base cloth on the market at present mainly adopts the materials such as viscose, polyester, polypropylene, polyethylene and the like. Although the non-woven fabric has the characteristics of moisture resistance, ventilation, flexibility, light weight, no combustion supporting, easy decomposition, no toxicity and irritation, rich color, low price, recycling and the like, the non-woven fabric also has a plurality of defects such as unsatisfactory affinity with skin, degradable material and the like; on the other hand, because the load of the mask base cloth to the essence is limited, the essence is generally wasted when the mask is used after the mask is unpacked.
The journal of International chemistry field, "journal of Material chemistry", A reports the research results of the Proprietary group of the southwest university of transportation Meng Tao, which utilizes the spider silk-like microfibers with hollow continuous channels to efficiently collect water, and the group team remarkably improves the water collection property of the fibers by constructing hollow structures inside the spider silk-like microfibers, and the research discovers that the suspended liquid drop volume of the bionic microfibers is 1663 times of the spindle section volume, and the water collection capacity value is far beyond that reported by the prior literature. Therefore, it can be speculated that the raw materials similar to the spider silk microfibers are made into the mask cloth, the load of the essence can be improved undoubtedly, and the essence waste caused by using the mask after packaging and unpacking is reduced. However, since the facial mask cloth containing the spider silk-like microfibers has a strong essence loading effect, the absorption and utilization of the essence by the skin are necessarily affected. It is possible that, due to the above complex and contradictory problems, there is no mask cloth containing a spider silk-like microfiber raw material in the existing market.
With the increasing demands of consumers on skin care products, the common mask cloth in the prior art has difficulty in meeting the market demands. Accordingly, there is a need for improvement in the above-described problems.
Disclosure of Invention
Based on a plurality of problems existing in the prior art about mask cloth, the application discloses mask cloth and a preparation method and application thereof. The inventor tries to prepare the raw material containing the imitated spider silk microfiber into the mask cloth based on the inspiration that the spider silk has super-strong moisture collecting effect, and solves the related difficulties and disadvantages in the preparation of the mask cloth.
The first aspect of the application provides a preparation method of mask cloth, which comprises the following steps:
(1) Preparing a mask base cloth: uniformly mixing the fiber stock solution and chitosan according to the mass ratio of 2:5-3:2 to obtain spinning solution, and preparing the mask base cloth by using an electrostatic spinning method; the fiber stock solution comprises a spider silk-like microfiber stock solution;
(2) Pretreatment of mask base cloth: placing the mask base cloth into bath liquid for pretreatment for 40-50 min; the bath liquid is an organic solvent containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid;
(3) Reprocessing the mask base cloth: and centrifugally dewatering the pretreated mask base cloth, and drying to obtain the mask cloth.
In one or more embodiments, the method for preparing the simulated spider silk microfiber stock in step (1) comprises: adding the water-based polyurethane and the calcium carbonate porous microspheres into water until the water-based polyurethane and the calcium carbonate porous microspheres are completely dissolved and uniformly dispersed in the solution, thus obtaining the spider silk-like microfiber stock solution.
In one or more embodiments, the fiber dope of step (1) further comprises at least one of hydroxyethyl cellulose, carboxymethyl cellulose, natural cellulose.
In one or more embodiments, the mass ratio of the spider silk-like microfibers to other fibers in the fiber stock solution is greater than 3:1.
In one or more embodiments, the ratio of sodium diisooctyl succinate to beta-hydroxy-beta-methylbutyric acid in step (2) is from 4:1 to 8:1.
In one or more embodiments, the organic solvent in the bath in step (2) is at least one of methanol, ethanol, ethylene glycol.
In one or more embodiments, the drying in the step (3) adopts a gradual heating method, and finally the temperature is raised to 150 ℃ and the drying is carried out for 3-5 min.
In one or more embodiments, the reworking of step (3) further includes pattern printing and/or cutting the resulting mask cloth.
The second aspect of the application provides a facial mask cloth which is prepared by any one of the methods of the application, has higher load capacity for essence and higher affinity for skin.
The third aspect of the application provides a facial mask comprising facial mask cloth and essence obtained by any one of the preparation methods of the application.
In one or more embodiments, the serum comprises, in parts by weight: 1-5 parts of hyaluronic acid, 5-6 parts of collagen and 20-40 parts of distilled water.
In another or more embodiments, the serum comprises, in parts by weight: 1-5 parts of hyaluronic acid, 2-3 parts of sodium polyglutamate, 5-6 parts of collagen, 0.4-0.7 part of green tea extract, 0.1-1 part of black spruce leaf extract, 0.6-0.8 part of mulberry leaf extract, 1-3 parts of raffinose, 0.7-1.2 parts of eucalyptus oil, 11-15 parts of glycerin, 1-3 parts of sucrose stearate and 20-40 parts of distilled water.
Compared with the prior art, the mask cloth prepared by the preparation method has the following advantages:
(1) The spider silk-like microfiber belongs to superfine fibers, and proper spider silk-like microfiber is added into the mask cloth, so that the essence load of the mask cloth can be increased, and the essence waste caused by unpacking the mask package in use is reduced;
(2) After the mask cloth is treated in a proper pretreatment liquid, the softness or elasticity of the mask cloth can be improved, and the use experience of consumers is improved;
(3) The pretreatment liquid of the mask cloth is added with a proper amount of beta-hydroxy-beta-methylbutyric acid, so that the use water retention effect of the mask configured by the mask cloth can be obviously improved.
Detailed Description
The facial mask cloth is a carrier of facial mask essence substances, and can be directly applied on the face. The most common type of facial mask cloth in the market at present is non-woven fabric, which is also called non-woven fabric, needled cotton, needled non-woven fabric and the like, and is manufactured by taking polyester fiber as a raw material through a needling process. However, the existing mask cloth has more or less problems such as unsatisfactory affinity with skin, limited loading amount of essence, and the like. The inventor continuously explores and researches materials of the mask cloth, and then the application is completed.
The term "spider silk-like microfiber" herein refers to an artificial fiber or artificial spider silk that mimics a spider silk structure.
Spiders are one of the precursors in nature that utilize air water sources. When a spider web is placed in a moist environment, the water vapor condenses on the surface of the captured silk therein forming droplets; the periodic spindle joint structure in the fiber causes the curvature radius of the capturing filament to change periodically, and the Laplace differential pressure is generated, so that the water drops are stressed unevenly along the radial direction of the fiber, and the water drops are pushed to move directionally (point to the spindle joint). The directional movement of the water drops is beneficial to the rapid collection of small liquid drops to form large water drops, so that the evaporation effect is weakened, and the rapid collection of water in the air is facilitated. The spider collects moisture in the air through the process to ensure survival, which provides a new thought for solving the freshwater crisis, and many related researches are in progress. For example, journal "journal of Material chemistry" A-journal of International chemistry field reports the research result of the Proc of the southwest university of transportation Meng Tao-by utilizing the spider silk-like microfiber with hollow continuous channel to collect water efficiently, the team can remarkably improve the water collection property of the fiber by constructing a hollow structure inside the spider silk-like microfiber, and the research finds that the suspended liquid drop volume of the bionic microfiber is 1663 times of the spindle section volume, and the water collection capacity value is far beyond that reported by the prior literature.
In addition, spider silk is a natural hydrogel fiber with a specific combination of properties, namely high strength, large elongation and high damping capacity, with higher toughness than other fiber materials. Previous studies have shown that spider silk has a core-shell structure, the core being an elastic core surrounded by a plastic outer layer, which is a critical part of the mechanical properties of the silk thread, while the outer layer provides some protection against external environmental influences.
Based on the characteristics of the spider silk-like microfibers, the inventor tries to use the spider silk-like microfibers as raw materials for preparing the mask cloth, and unexpectedly discovers that the preparation of the spider silk-like microfibers into the mask cloth can improve the load of essence and reduce the essence waste caused by the use of the mask after the packaging and unpacking of the mask. However, the mask cloth simply comprising the raw material of the spider silk-like microfiber is disadvantageous for consumers to use because the super water absorption thereof causes the mask essence to be hardly absorbed by the skin.
The inventor has unexpectedly found that, after the prepared mask base cloth is soaked in an organic solvent containing diisooctyl succinate sodium sulfonate and beta-hydroxy-beta-methylbutyric acid, the essence of the mask can be well absorbed by skin, so that the problems are solved.
The sodium diisooctyl succinate can form a net structure with the fibers in the mask base cloth, wherein the sodium diisooctyl succinate and the fibers have strong binding force and are combined on the surfaces of the fibers, so that the friction force among the fibers is reduced, and the softness of the mask cloth is improved.
The term "beta-hydroxy-beta-methylbutyric acid", also known as hydroxymethylbutyric acid or abbreviated HMB, herein is a metabolite of leucine that has been used by body-building and other athletes to promote muscle expansion. HMB appears to continuously attenuate muscle catabolism in the event that muscle atrophy is expected.
HMB is considered to be a precursor of HMG-coa reductase, a rate-limiting enzyme for cholesterol synthesis, an inhibitor of the ubiquitin-proteasome proteolytic pathway responsible for intracellular protein degradation, and a protein synthesis promoter through an mTOR dependent mechanism. HMB is also thought to induce muscle proliferation via the MAPK/ERK pathway (Kornasio R,et al.Beta-hydroxy-beta-methylbutyrate(HMB)stimulates myogenic cell proliferation,differentiation andsurvival via the MAPK/ERK and PI3K/Akt pathways"Biochim Biophys Acta(2009)) and/or the mTOR pathway (Pimentel GD,et al."β-Hydroxy-β-methylbutyrate(HMβ)supplementation stimulates skeletal muscle hypertrophy in rats via the mTORpathway"Nutr Metab(Lond)(2011)).
HMB can also reduce apoptosis in muscle cells (Kornasio R, etc.), which tends to increase during catabolic processes associated with aging and cachexia. HMB supplementation with increased ATP and glycogen levels (Pinheiro CH,et al."Metabolic and functional effects of beta-hydroxy-beta-methylbutyrate(HMB)supplementation in skeletal muscle"Eur J Appl Physiol(2012)). in skeletal muscle it was noted that HMB may reduce creatine kinase levels after exercise in trained men (sign of muscle injury )(Wilson JM,etal."β-Hydroxy-β-methylbutyrate free acid reduces markers of exercise-inducedmuscledamage and improves recovery in resistance-trained men"Br J Nutr(2013)).HMB may also help to reduce pain after weight lifting) (van Someren KA et al."Supplementationwith beta-hydroxy-beta-methylbutyrate(HMB)and alpha-ketoisocaproic acid(KIC)reduces signs and symptoms of exercise-induced muscledamage in man"Int JSport Nutr Exerc Metab(2005)).
HMB is typically provided as a calcium salt or as the free acid. The free acid form is believed to have higher bioavailability, higher Cmax and area under the curve (AUC), although the calcium salt is believed to remain in the body for longer periods of time. All endogenous HMB is derived from dietary leucine, so HMB levels are related to dietary leucine intake, with only about 5% of leucine oxidized in vivo to form HMB. One problem with calcium HMB is that it absorbs poorly in at least some individuals. In order to improve absorption, other salts than the free acid form may be preferred, such as sodium HMB, potassium HMB, magnesium HMB and amino acid salts of HMB.
The prior literature has investigated various biological effects of HMB, which, although positive results are often noted, generally appear to be relatively small or somewhat inconsistent, and there is no report of the use of HMB in facial masks. Thus, while HMB appears to have great potential to achieve various health benefits, it is still being further investigated and applied in a wider field.
Specifically, the application provides a preparation method of mask cloth, which comprises the following steps:
(1) Preparing a mask base cloth: uniformly mixing the fiber stock solution and chitosan according to the mass ratio of 2:5-3:2 to obtain spinning solution, and preparing the mask base cloth by using an electrostatic spinning method; the fiber stock solution comprises a spider silk-like microfiber stock solution;
(2) Pretreatment of mask base cloth: placing the mask base cloth into bath liquid for pretreatment for 40-50 min; the bath liquid is an organic solvent containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid;
(3) Reprocessing the mask base cloth: and centrifugally dewatering the pretreated mask base cloth, and drying to obtain the mask cloth.
In one or more embodiments, the method of preparing the simulated spider silk microfiber stock in step (1) comprises: adding the water-based polyurethane and the calcium carbonate porous microspheres into water until the water-based polyurethane and the calcium carbonate porous microspheres are completely dissolved and uniformly dispersed in the solution, thus obtaining the spider silk-like microfiber stock solution.
In one or more embodiments, the fiber dope of step (1) further comprises at least one of hydroxyethyl cellulose, carboxymethyl cellulose, natural cellulose.
In one or more embodiments, the mass ratio of the spider silk-like microfibers to other fibers in the fiber stock solution is greater than 3:1.
In one or more embodiments, the ratio of sodium diisooctyl succinate to beta-hydroxy-beta-methylbutyric acid in step (2) is from 4:1 to 8:1.
In one or more embodiments, the organic solvent in the bath in step (2) is at least one of methanol, ethanol, ethylene glycol.
In one or more embodiments, the drying in step (3) is performed by a gradual heating method, and the temperature is finally increased to 150 ℃ and the drying is performed for 3-5 min.
In one or more embodiments, the reworking of step (3) further includes pattern printing and/or cutting the resulting mask cloth.
The application also comprises the mask cloth which is prepared by any one of the methods, has higher load capacity for essence and higher affinity for skin.
The application also comprises a facial mask which comprises facial mask cloth and essence obtained by any one of the preparation methods.
In one or more embodiments, the serum comprises, in parts by weight: 1-5 parts of hyaluronic acid, 5-6 parts of collagen and 20-40 parts of distilled water.
In another or more embodiments, the serum comprises, in parts by weight: 1-5 parts of hyaluronic acid, 2-3 parts of sodium polyglutamate, 5-6 parts of collagen, 0.4-0.7 part of green tea extract, 0.1-1 part of black spruce leaf extract, 0.6-0.8 part of mulberry leaf extract, 1-3 parts of raffinose, 0.7-1.2 parts of eucalyptus oil, 11-15 parts of glycerin, 1-3 parts of sucrose stearate and 20-40 parts of distilled water.
The present invention will be described in further detail with reference to specific examples. It should be understood that the following examples are illustrative of the present invention and are not intended to limit the scope of the present invention.
Examples
All materials, reagents and equipment selected herein are well known in the art, but are not limiting to the practice of the invention, and other reagents and equipment known in the art may be suitable for the practice of the following embodiments of the invention.
The amounts, amounts and concentrations of various substances are referred to herein, wherein the percentages refer to percentages by mass unless otherwise specified.
Materials and methods:
Preparing spider silk microfiber stock solution: adding the water-based polyurethane and a small amount of calcium carbonate porous microspheres into water until the water-based polyurethane and the small amount of calcium carbonate porous microspheres are completely dissolved and uniformly dispersed in the solution, thus obtaining the spider silk-like microfiber stock solution.
Preparation of a mask: the mask cloth prepared in the following examples and comparative examples is folded and filled into Cheng Zhuangdai, and a proper amount of essence is added and then the mask cloth is packaged; the essence comprises the following components in parts by weight: 1-5 parts of hyaluronic acid, 5-6 parts of collagen and 20-40 parts of distilled water.
Hydrophilic testing of mask cloth: the mask cloth prepared by the methods of each example and comparative example was tested according to AATCC-79 test method; the shorter the water droplet wetting time, the better the hydrophilicity.
Softness test of mask cloth: subjective hand feeling test is carried out on the mask cloth through a fabric expert; the softness of the mask cloth is divided into 6 grades, namely 1 is very soft, 2 is soft, 3 is softer, 4 is harder, 5 is hard and 6 is very hard.
Moisture retention test of mask: and taking out the mask, applying the mask for 15-20min, measuring the moisture percentage of each part at 0, 60 and 120min by using an intelligent moisture tester, repeating the test 5 times each time, and taking an average value.
Example 1:
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing the spider silk-like microfiber stock solution and chitosan according to a mass ratio of 1:2 to obtain spinning solution, and preparing the mask base cloth by electrostatic spinning;
(2) Pretreatment of mask base cloth: placing the mask base cloth into an ethanol bath solution containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid for pretreatment for 45min; the mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid is 6:1;
(3) Reprocessing the mask base cloth: and (3) centrifugally dewatering the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ for 1min, and drying for 4min to obtain mask cloth A.
Example 2:
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing the fiber stock solution and chitosan according to the mass ratio of 1:2 to obtain spinning solution, and preparing the mask base cloth by using an electrostatic spinning method; the fiber stock solution is formed by mixing spider silk-like microfibers and hydroxyethyl cellulose according to the mass ratio of 10:1;
(2) Pretreatment of mask base cloth: placing the mask base cloth into ethylene glycol bath liquid containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid for pretreatment for 45min; the mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid is 5:1;
(3) Reprocessing the mask base cloth: and (3) centrifugally dewatering the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ in 30S, and drying for 4min to obtain mask cloth B.
Example 3:
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing the fiber stock solution and chitosan according to the mass ratio of 1:1 to obtain spinning solution, and preparing the mask base cloth by using an electrostatic spinning method; the fiber stock solution is formed by mixing spider silk-like microfibers, hydroxyethyl cellulose and carboxymethyl cellulose according to the mass ratio of 8:1:1;
(2) Pretreatment of mask base cloth: placing the mask base cloth into ethylene glycol bath liquid containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid for pretreatment for 45min; the mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid is 4:1;
(3) Reprocessing the mask base cloth: and (3) centrifugally dewatering the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ in 30S, and drying for 5min to obtain mask cloth C.
Example 4:
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing the fiber stock solution and chitosan according to the mass ratio of 2:5 to obtain spinning solution, and preparing the mask base cloth by using an electrostatic spinning method; the fiber stock solution is formed by mixing spider silk-like microfibers, hydroxyethyl cellulose and carboxymethyl cellulose according to the mass ratio of 10:1:1;
(2) Pretreatment of mask base cloth: placing the mask base cloth into an organic solution containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid for pretreatment for 45min; the mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid is 8:1; the organic solution is a solution prepared by methanol and ethanol in equal volume;
(3) Reprocessing the mask base cloth: and (3) centrifugally dewatering the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ in 30S, and drying for 5min to obtain the mask cloth D.
Comparative example 1: the addition amount of chitosan is too high
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing the spider silk-like microfiber stock solution and chitosan according to a mass ratio of 1:5 to obtain spinning solution, and preparing the mask base cloth by electrostatic spinning;
(2) Pretreatment of mask base cloth: placing the mask base cloth into an ethanol bath solution containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid for pretreatment for 45min; the mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid is 6:1;
(3) Reprocessing the mask base cloth: and (3) centrifugally dewatering the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ for 1min, and drying for 4min to obtain the mask cloth E.
Comparative example 2: the addition amount of chitosan is too low
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing the spider silk-like microfiber stock solution and chitosan according to a mass ratio of 5:1 to obtain spinning solution, and preparing the mask base cloth by electrostatic spinning;
(2) Pretreatment of mask base cloth: placing the mask base cloth into an ethanol bath solution containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid for pretreatment for 45min; the mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid is 6:1;
(3) Reprocessing the mask base cloth: and (3) centrifugally dewatering the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ for 1min, and drying for 4min to obtain the mask cloth F.
Comparative example 3: the proportion of the pretreatment liquid is out of range
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing the spider silk-like microfiber stock solution and chitosan according to a mass ratio of 1:2 to obtain spinning solution, and preparing the mask base cloth by electrostatic spinning;
(2) Pretreatment of mask base cloth: placing the mask base cloth into an ethanol bath solution containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid for pretreatment for 45min; the mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid is 3:1;
(3) Reprocessing the mask base cloth: and (3) centrifugally dewatering the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ for 1min, and drying for 4min to obtain the mask cloth G.
Comparative example 4: the proportion of the pretreatment liquid is out of range
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing the spider silk-like microfiber stock solution and chitosan according to a mass ratio of 1:2 to obtain spinning solution, and preparing the mask base cloth by electrostatic spinning;
(2) Pretreatment of mask base cloth: placing the mask base cloth into an ethanol bath solution containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid for pretreatment for 45min; the mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid is 9:1;
(3) Reprocessing the mask base cloth: and (3) centrifugally dewatering the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ for 1min, and drying for 4min to obtain mask cloth H.
Comparative example 5: no addition of spider silk-like microfibers
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing hydroxyethyl cellulose and chitosan according to a mass ratio of 1:2 to obtain spinning solution, and preparing a mask base cloth by an electrostatic spinning method;
(2) Pretreatment of mask base cloth: placing the mask base cloth into an ethanol bath solution containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid for pretreatment for 45min; the mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid is 5:1;
(3) Reprocessing the mask base cloth: and (3) centrifugally dewatering the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ for 1min, and drying for 4min to obtain the mask cloth I.
Comparative example 6: unused beta-hydroxy-beta-methylbutyric acid
A facial mask cloth, the method comprising the steps of:
(1) Preparing a mask base cloth: uniformly mixing the spider silk-like microfiber stock solution and chitosan according to a mass ratio of 1:2 to obtain spinning solution, and preparing the mask base cloth by electrostatic spinning;
(2) Pretreatment of mask base cloth: placing the mask base cloth into an ethanol bath solution containing diisooctyl succinate sodium sulfonate for pretreatment for 45min;
(3) Reprocessing the mask base cloth: and (3) centrifugally dehydrating the pretreated mask base cloth, drying by adopting a gradual heating method, heating to 150 ℃ for 1min, and drying for 4min to obtain the mask cloth J.
The following are the results of hydrophilicity test and softness test of the mask cloths prepared in each example and comparative example (table 1), and the results of skin moisturization test after preparing these mask cloths into a mask (table 2):
Table 1 results of hydrophilicity test and softness test of mask cloth
Examples/comparative examples | Mask cloth | Drop wetting time (S) | Softness rating |
Example 1 | A | 5 | 1 |
Example 2 | B | 6 | 1 |
Example 3 | C | 6 | 1 |
Example 4 | D | 7 | 1 |
Comparative example 1 | E | 19 | 1 |
Comparative example 2 | F | 7 | 1 |
Comparative example 3 | G | 8 | 2 |
Comparative example 4 | H | 9 | 3 |
Comparative example 5 | I | 21 | 1 |
Comparative example 6 | J | 9 | 3 |
Table 2 skin moisturization test results of mask
As can be seen from Table 1, the mask cloths prepared in examples 1 to 4 were higher in hydrophilicity, and the hydrophilicity of comparative example 1 was much lower than that of examples 1 to 4 because of the addition of less spider silk-like microfibers, and the hydrophilicity of comparative example 5 was lowest because of the absence of the addition of spider silk-like microfibers, and comparative examples 2 to 4 and comparative example 6 appeared to be comparable to that of examples 1 to 4. The results of Table 1 are combined, the addition of the imitated spider silk microfibers is a key factor affecting the mask cloth of the application, and a good hydrophilic effect can be achieved only by adding a certain amount of the imitated spider silk microfibers, and the pretreatment liquid does not seem to affect the hydrophilicity of the mask cloth. Therefore, the proper spider silk-like microfiber is added into the mask cloth, so that the essence load of the mask cloth can be increased, and the essence waste caused by using the mask cloth after packaging and unpacking is reduced.
As can be seen from Table 1, the mask cloths prepared in examples 1 to 4 were very soft, indicating good elasticity. In addition, comparative examples 3,4 and 6 were poor in softness of the mask cloth due to the change in the ratio of sodium diisooctyl succinate and β -hydroxy- β -methylbutyric acid in the pretreatment liquid, whereas comparative examples 1, 2 and 5 were not poor in softness of the mask cloth due to the change in the raw material composition of the mask cloth. The result of the table 1 is synthesized, and the proportion of the diisooctyl succinate sodium sulfonate and the beta-hydroxy-beta-methylbutyric acid in the pretreatment liquid is a key factor of the softness performance of the mask cloth, so that the softness or elasticity of the mask cloth can be improved after the mask cloth is treated in a proper pretreatment liquid, and the use experience of consumers is improved.
As is clear from Table 2, the water content of the skin was remarkably increased after using the mask composed of the mask cloths prepared in examples 1 to 4 and comparative examples 1 to 2, the water content of the skin was poor after using the mask composed of the mask cloths prepared in comparative examples 3 to 5, and the water content of the skin was worst after using the mask composed of the mask cloth prepared in comparative example 6. According to analysis, whether the beta-hydroxy-beta-methyl butyric acid is added or not and the addition amount are key to the use effect of the mask cloth after being configured into a mask are shown. Therefore, the pretreatment liquid of the mask cloth is added with a proper amount of beta-hydroxy-beta-methylbutyric acid, so that the use water retention effect of the mask configured by the mask cloth can be obviously improved.
The present invention is not limited to the above-mentioned embodiments, and any changes or substitutions that can be easily understood by those skilled in the art within the technical scope of the present invention are intended to be included in the scope of the present invention.
Claims (6)
1. The preparation method of the superfine fiber mask cloth is characterized by comprising the following steps of:
(1) Preparing a mask base cloth: uniformly mixing the fiber stock solution and chitosan according to the mass ratio of 2:5-3:2 to obtain spinning solution, and preparing the mask base cloth by using an electrostatic spinning method; the fiber stock solution comprises a spider silk-like microfiber stock solution;
The preparation method of the spider silk-like microfiber stock solution comprises the following steps:
adding the water-based polyurethane and the calcium carbonate porous microspheres into water until the water-based polyurethane and the calcium carbonate porous microspheres are completely dissolved and uniformly dispersed in the solution, thus obtaining the spider silk-like microfiber stock solution;
Wherein the fiber stock solution further comprises at least one of hydroxyethyl cellulose, carboxymethyl cellulose and natural cellulose; the mass ratio of the spider silk-like microfiber stock solution to other fibers in the fiber stock solution is greater than 3:1;
(2) Pretreatment of mask base cloth: placing the mask base cloth into bath liquid for pretreatment for 40-50 min; the bath liquid is an organic solvent containing sodium diisooctyl succinate and beta-hydroxy-beta-methylbutyric acid;
(3) Reprocessing the mask base cloth: centrifugally dewatering the pretreated mask base cloth, and drying to obtain mask cloth;
The mass ratio of the sodium diisooctyl succinate to the beta-hydroxy-beta-methylbutyric acid in the step (2) is 4:1-8:1.
2. The method of claim 1, wherein the organic solvent in the bath solution in the step (2) is at least one of methanol, ethanol and ethylene glycol.
3. The method for preparing mask cloth according to claim 1, wherein the drying in the step (3) is performed by a gradual heating method, and the temperature is raised to 150 ℃ and the drying is performed for 3-5 minutes.
4. The method of producing a mask cloth according to claim 1, wherein the reworking in step (3) further comprises printing and/or cutting a pattern on the obtained mask cloth.
5. A facial mask cloth prepared by the method of any one of claims 1-4.
6. A facial mask, which is characterized by comprising the facial mask cloth and essence according to claim 5, wherein the essence comprises the following components in parts by weight: 1-5 parts of hyaluronic acid, 5-6 parts of collagen and 20-40 parts of distilled water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311762387.XA CN117503617B (en) | 2023-12-20 | 2023-12-20 | Superfine fiber mask cloth and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311762387.XA CN117503617B (en) | 2023-12-20 | 2023-12-20 | Superfine fiber mask cloth and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117503617A CN117503617A (en) | 2024-02-06 |
CN117503617B true CN117503617B (en) | 2024-08-30 |
Family
ID=89753244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311762387.XA Active CN117503617B (en) | 2023-12-20 | 2023-12-20 | Superfine fiber mask cloth and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117503617B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109610164A (en) * | 2018-10-18 | 2019-04-12 | 青岛即发集团股份有限公司 | A kind of chitin fiber facial mask cloth and preparation method thereof |
TWM610668U (en) * | 2020-09-26 | 2021-04-21 | 大江生醫股份有限公司 | Biological fiber membrane cloth with spider silk protein and biological fiber mask with spider silk protein |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003060099A2 (en) * | 2002-01-11 | 2003-07-24 | Nexia Biotechnologies, Inc. | Methods and apparatus for spinning spider silk protein |
CN110914488B (en) * | 2017-07-01 | 2022-01-07 | 中国石油化工股份有限公司 | Spider silk-like polymer fibers, method for producing same, and use thereof |
CN111135120B (en) * | 2018-11-06 | 2021-04-20 | 万华化学集团股份有限公司 | Waterborne polyurethane functional surface film matrix and application thereof |
EP4175977A4 (en) * | 2020-07-05 | 2024-10-02 | Seevix Mat Sciences Ltd | Highly porous spider silk fibers |
CN213564770U (en) * | 2020-07-07 | 2021-06-29 | 广州雅南无纺布制品有限公司 | Elastic lifting and tightening membrane cloth based on elastic fibers and water-absorbing plant fibers |
CN112176525B (en) * | 2020-09-24 | 2021-10-08 | 浙江王金非织造布有限公司 | One-way water guide mask base material and preparation method thereof |
CN117071164B (en) * | 2023-10-12 | 2024-02-13 | 昂森新材料(广州)有限公司 | Marine grape mask cloth and preparation device thereof |
-
2023
- 2023-12-20 CN CN202311762387.XA patent/CN117503617B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109610164A (en) * | 2018-10-18 | 2019-04-12 | 青岛即发集团股份有限公司 | A kind of chitin fiber facial mask cloth and preparation method thereof |
TWM610668U (en) * | 2020-09-26 | 2021-04-21 | 大江生醫股份有限公司 | Biological fiber membrane cloth with spider silk protein and biological fiber mask with spider silk protein |
Also Published As
Publication number | Publication date |
---|---|
CN117503617A (en) | 2024-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69726191T2 (en) | SYNTHETIC FIBER FABRICS WITH IMPROVED HYDROPHILIC PROPERTIES AND IMPROVED WEARING COMFORT | |
US10682257B2 (en) | Biological fiber composite dressing | |
US20180023216A1 (en) | Functionalized molded cellulose body and method for producing the same | |
JP4918481B2 (en) | Fiber fabric and fiber processing method | |
WO2020113902A1 (en) | Regenerated cellulose fiber containing ceramide microcapsule and preparation method therefor | |
CN110172826A (en) | A kind of fabric of moisturizing containing sodium hyaluronate | |
CN108690223A (en) | A kind of layered double hydroxide/fibrination hole composite material and preparation method thereof | |
CN108056934A (en) | Film and its manufacturing method and corresponding polymer comprising core-shell type nano fiber | |
CN108403446A (en) | A kind of bamboo-carbon viscose fibre mask substrate and high water lock moisture saver mask | |
CN106283391A (en) | A kind of film cloth used for cosmetic and processing method thereof | |
EP1771619A1 (en) | Dressings which can be applied several times to textile fibres and textile fabrics | |
CN107898657A (en) | Eye mask containing stem cell secretion factors | |
CN117503617B (en) | Superfine fiber mask cloth and preparation method and application thereof | |
CN106974874A (en) | A kind of deep water supplement moisturizing silk mask and preparation method thereof | |
CN106109261A (en) | Whitening and skin-brightening emulsion and preparation method thereof | |
CN111973494A (en) | Long-acting moisturizing type moisturizing cream and preparation method thereof | |
CN106283392A (en) | A kind of film cloth used for cosmetic and processing method thereof and purposes | |
KR100879822B1 (en) | Process for preparing cosmetic mask pack from thallus of sea tangle | |
CN109646372A (en) | One kind scalp care compositions of leaf extract containing aloe barbadensis Miller and preparation method thereof | |
CN107693418A (en) | One kind nourishes anti-chap camellia oleifera fruit hand lotion and preparation method thereof | |
CN111939085A (en) | Preparation method of silk mask and product | |
CN110029443A (en) | A kind of camellia seed oil fiber coating materials and the preparation method and application thereof | |
CN113786361A (en) | Eye cream composition with pouch removing effect and preparation method thereof | |
CN113018517A (en) | 3D printing skin stent and preparation method and application thereof | |
DE69531496T2 (en) | ALGINATE FIBERS, METHOD FOR THE PRODUCTION AND USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |